Log in to save to my catalogue

The Inflammatory Marker YKL-40 Is Elevated in Cerebrospinal Fluid from Patients with Alzheimer’s but...

The Inflammatory Marker YKL-40 Is Elevated in Cerebrospinal Fluid from Patients with Alzheimer’s but...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_plos_journals_1704980354

The Inflammatory Marker YKL-40 Is Elevated in Cerebrospinal Fluid from Patients with Alzheimer’s but Not Parkinson’s Disease or Dementia with Lewy Bodies

Publication information

Publisher

United States: Public Library of Science

More information

Scope and Contents

Contents

A major difference in the revised diagnostic criteria for Alzheimer's disease (AD) is the incorporation of biomarkers to support a clinical diagnosis and allow the identification of preclinical AD due to AD neuropathological processes. However, AD-specific fluid biomarkers which specifically distinguish clinical AD dementia from other dementia diso...

Alternative Titles

Full title

The Inflammatory Marker YKL-40 Is Elevated in Cerebrospinal Fluid from Patients with Alzheimer’s but Not Parkinson’s Disease or Dementia with Lewy Bodies

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_plos_journals_1704980354

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_plos_journals_1704980354

Other Identifiers

ISSN

1932-6203

E-ISSN

1932-6203

DOI

10.1371/journal.pone.0135458

How to access this item

Log in as a Library member